Package 62559-221-01

{"route": ["ORAL"], "spl_id": "00918074-5761-4530-bb20-5cbf3efb84e8", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0362559221016", "0362559222051", "0362559222013", "0362559220057"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["867eaf99-3e31-4f75-bfae-2898804d956d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (62559-221-01)", "package_ndc": "62559-221-01", "marketing_start_date": "20250715"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (62559-221-05)", "package_ndc": "62559-221-05", "marketing_start_date": "20250715"}], "brand_name": "Oxcarbazepine", "product_id": "62559-221_00918074-5761-4530-bb20-5cbf3efb84e8", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "62559-221", "generic_name": "Oxcarbazepine", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/1"}], "application_number": "ANDA078005", "marketing_category": "ANDA", "marketing_start_date": "20250715", "listing_expiration_date": "20261231"}